Brussels, 27/04/2000 (Agence Europe) - The Community regulation on orphan drugs (Council and Parliament Regulation 141/2000, in force since 22 January 2000), which opens up new treatment opportunities for patients suffering from rare or "orphan" diseases, is now ready to be implemented. The European Commission has adopted an implementing regulation containing the definitions and criteria needed for implementation of the measures to encourage the pharmaceutical industry to invest in the...